United States · FDA National Drug Code directory
ziprasidone
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 55111-258_8c954cc0-a912-9c0a-93d9-9264d8a63c79
- Product NDC
- 55111-258
- Form
- CAPSULE
- Composition / generic term
- ziprasidone
- Labeler
- Dr. Reddy's Laboratories Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20120302
- Source listing expiry
- 20271231
Source-listed ingredients
- ZIPRASIDONE HYDROCHLORIDE — 60 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE in 1 BOTTLE (55111-258-01) · 55111-258-01
- 500 CAPSULE in 1 BOTTLE (55111-258-05) · 55111-258-05
- 30 CAPSULE in 1 BOTTLE (55111-258-30) · 55111-258-30
- 60 CAPSULE in 1 BOTTLE (55111-258-60) · 55111-258-60
- 10 BLISTER PACK in 1 CARTON (55111-258-78) / 10 CAPSULE in 1 BLISTER PACK · 55111-258-78
- 3 BLISTER PACK in 1 CARTON (55111-258-81) / 10 CAPSULE in 1 BLISTER PACK · 55111-258-81
- 90 CAPSULE in 1 BOTTLE (55111-258-90) · 55111-258-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →